Popat R, Harrison S, Riley CH, Mian H, Spencer A, Lavi N, Paris L, Jelínek T, Szarejko M, Grosicki S, Kim K, Sandhu I, Chebon S, Tyagi T, Sewpaul P, Richardson L, Trunzer K, Mishra A, Trudel S. P34 | CEVOSTAMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: BIOMARKER ANALYSES FROM CAMMA 1 ARM B. Haematologica 2026; 111(s2); https://doi.org/10.3324/haematol.2026.s2.14083.